Table 4. Primary, Secondary, and Safety Outcomes in Patients With Initial Systolic Blood Pressure Less Than 220 mm Hg, According to Treatment Groups.
| Outcome | Patients, No. (%) | Relative risk (95% CI) | |
|---|---|---|---|
| Intensive treatment (n = 390) | Standard treatment (n = 381) | ||
| Primary outcome (death or disability), No./total No. (%)a | 145/376 (38.6) | 138/367 (37.6) | 1.03 (0.85-1.23) |
| Hematoma expansion, No./total No. (%) | 80/382 (20.9) | 108/370 (29.2) | 0.72 (0.56-0.92) |
| Neurologic deterioration within 24 h | 38 (9.7) | 32 (8.4) | 1.16 (0.74-1.82) |
| Treatment-associated serious adverse event within 72 h | 5 (1.3) | 5 (1.3) | 0.98 (0.29-3.35) |
| Any serious adverse event within 3 mo | 98 (25.1) | 78 (20.5) | 1.23 (0.94-1.59) |
| Kidney adverse event within 7 d of discharge | 30 (7.7) | 15 (3.9) | 1.95 (1.07-3.57) |
| Kidney serious adverse event within 7 d of discharge | 2 (0.5) | 0 | NA |
Abbreviation: NA, not available.
a
Death or disability data at 90 days were available for 743 patients.